We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 10 for:    morken
Previous Study | Return to List | Next Study

Bipolar Research And Innovation Network - BRAIN

This study is currently recruiting participants.
Verified December 2017 by Norwegian University of Science and Technology
Sponsor:
ClinicalTrials.gov Identifier:
NCT00201526
First Posted: September 20, 2005
Last Update Posted: December 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
University of Oslo
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.

Condition
Bipolar Disorder

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Bipolar Research And Innovation Network - BRAIN

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • characterization of bipolar disorders [ Time Frame: 15 years ]

Biospecimen Retention:   Samples With DNA
Blood samples

Estimated Enrollment: 3000
Actual Study Start Date: January 2003
Estimated Study Completion Date: January 2020
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)
Detailed Description:

Norway is both social, genetically and culturally a homogeneous society. The health service is public and has a nearly total responsibility for psychiatric care in given catchment areas. This provides excellent opportunities to describe the frequencies and patterns of the broad spectrum of bipolar illness, including co-morbid substance use disorders, to follow the patients for several years and to do molecular genetic mapping.

Methods: Participating centers consist of outpatient clinics and hospital departments from different parts of Norway and one third-line clinic with referrals from all over Norway. Specifically trained clinicians in each center include bipolar patients systematically and perform the patient evaluation as part of their clinical duties. In addition, CT or MRI scans and EEG are performed and blood samples are collected for clinical chemistry screening and for DNA sampling.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Secondary care clinics
Criteria

Inclusion Criteria:

  • All admitted patients giving written consent to participate in the study

Exclusion Criteria:

  • Patients without competence for consent.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00201526


Contacts
Contact: Gunnar Morken, PhD MD +47 72823034 gunnar.morken@ntnu.no

Locations
Norway
Medical Faculty, Norwegian University of Science And Technology Recruiting
Trondheim, Norway, 7441
Contact: Gunnar Morken, MD PhD    +4772823034    gunnar.morken@ntnu.no   
Principal Investigator: Gunnar Morken, MD PhD         
Sponsors and Collaborators
Norwegian University of Science and Technology
University of Oslo
Investigators
Principal Investigator: Gunnar Morken, PhD MD Norwegian University of Science and Technology
  More Information

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00201526     History of Changes
Other Study ID Numbers: BRAIN-04
First Submitted: September 16, 2005
First Posted: September 20, 2005
Last Update Posted: December 11, 2017
Last Verified: December 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Bipolar Disorder

Additional relevant MeSH terms:
Bipolar Disorder
Bipolar and Related Disorders
Mental Disorders